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Hunger increases physical activity and stamina to support food-directed foraging behaviors, but underlying
mechanisms are unclear. In this issue, Fernandes et al. (2015) show that disruption of leptin-regulated STAT3
signaling in midbrain dopamine neurons increases the rewarding effects of running in mice, which could
explain the ‘‘high’’ experienced by endurance runners.It might be expected that hungry animals
reduce their energy expenditure to
conserve already depleted energy re-
serves. However, humans and rodents
often increase physical activity when
hungry. Hunger also increases sensitivity
of brain reward systems (Carr, 1996).
Conceptually, this increase in reward
function serves to enhance the motiva-
tional value of physical activity, which in
turn facilitates foraging behaviors, and
increases pleasure derived from suc-
cessful foraging, a powerful combination
in the context of food seeking. Currently,
it is unclear how energy balance is
coupled to physical activity. Also unclear
is whether the same brain systems regu-
late the enhanced rewarding value of
physical activity and food during hunger
states.
Circulating leptin levels are usually
reduced in hungry animals, which pro-
motes physical activity when food is
limited. Infusion of leptin into the ventral
tegmental area (VTA), a brain site in which
dopamine-containing neurons play a key
role in regulating motivated behaviors,
suppresses hyperactivity during starva-
tion (Verhagen et al., 2011). This suggests
that leptin signaling in the VTA may
link energy status to physical activity.
In this issue, Fernandes et al. (2015) pro-
vide compelling evidence supporting this
hypothesis.
Leptin acts in neurons primarily through
STAT3 (signal transducer and activator
of transcription 3) (Bates et al., 2003).
To investigate the role for dopamine neu-
rons in regulating the behavioral actions
of leptin, Fernandes et al. (2015) con-
ditionally deleted STAT3 in these neurons.
This was accomplished by crossing mice540 Cell Metabolism 22, October 6, 2015 ª20with loxP sites flanking exon 22 of the
STAT3 gene with those expressing Cre
recombinase under the control of the
dopamine transporter gene (DAT), thereby
generating STAT3DAT knockout (KO)mice.
Although daily food intake, heat dissipa-
tion, and respiratory exchange were not
impacted, the body weight of STAT3DAT
KO mice was significantly lower than
control mice. This effect was explained
by a dramatic increase in their physical ac-
tivity. When a running wheel was made
available, the KO mice ran almost twice
as much as control mice (11 versus 6 km
day1). This increase in physical activity
is unlikely to be explained by alterations
in anxiety-related behaviors, as KO
and control mice demonstrated similar
behavior in an elevated-plus maze and
open field. Importantly, virus-mediated
re-expression of STAT3 selectively in
VTA dopamine neurons normalized
running behavior in the conditional KO
mice, confirming their role in the observed
effects. The findings suggest that leptin,
acting through STAT3 in VTA dopamine
neurons, controls levels of physical activity
in mice.
Next, the authors investigated the
mechanisms by which STAT3 controls
running. Using a place conditioning proce-
dure, they found that STAT3DAT KO mice
spent farmore time thancontrols exploring
an environment in which a running wheel
was previously available. This suggests
that the rewarding properties of running
were greatly potentiated in the KO mice.
Interestingly, STAT3DAT KO mice did not
demonstrate any evidence for altered
sensitivity to rewarding properties of palat-
able food. Anorectic responses to leptin
were also unaltered in the KO mice. This15 Elsevier Inc.provides strong evidence that STAT3
signaling in VTA inhibits the rewarding
properties of physical activity, but not
food, and raises the interesting issue of
where in the brain leptin acts to regulate
food reward. The lateral hypothalamus
(LH) is considered a core component of
the brain reward system, and its sensitivity
to reward is influenced by hunger in a lep-
tin-dependentmanner (Fulton et al., 2000).
Moreover, leptin was recently shown to
activate STAT3 signaling in a population
of inhibitory neurons in LH, which sup-
pressed food intake in mice (Leinninger
et al., 2009). Interestingly, these leptin-
responsive LH neurons directly innervate
VTA dopamine neurons (Leinninger et al.,
2009). Hence, leptin likely acts in the VTA
and LH to control the rewarding effects of
physical activity and food, respectively,
with these sites sharing close leptin-regu-
lated functional interactions.
Finally, the authors investigated mech-
anisms by which STAT3 signaling in
dopamine neurons controls running. Psy-
chomotor stimulants such as amphet-
amine and cocaine increase locomotor
activity by stimulating dopamine trans-
mission in nucleus accumbens (NAc).
Dopamine signaling in NAc is hypo-
thesized to regulate the rewarding proper-
ties of wheel running (Roberts et al.,
2012). It is therefore surprising that the
STAT3DAT KO mice demonstrated a pro-
found deficit in evoked dopamine release
into the core of the NAc. The KO mice
also demonstrated diminished sensitivity
to the locomotor stimulant effects of
amphetamine and a dopamine D1 recep-
tor agonist. Considering the well-estab-
lished role for dopamine in regulating
motor behavior, these findings appear
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consistent with recent data showing that
running distance is inversely correlated
with evoked dopamine release in NAc in
rats (Tarr et al., 2004) and that hyperloco-
motion can occur independent of dopa-
mine transmission in NAc (Chartoff et al.,
2005). How does ablation of STAT3
signaling in VTA dopamine neurons,
concomitant with reductions in evoked
dopamine release in NAc, precipitate
such dramatic increases in the rewarding
properties of running? The authors
offered a tantalizing piece of preliminary
evidence suggesting that the STAT3DAT
KO mice have reduced pre-prodynorphin
mRNA levels in the VTA. Pre-prodynor-
phin is produced by the so called ‘‘direct
pathway’’ medium spiny neurons in stria-
tum, which provide feedback innervation
to the midbrain dopamine system. More-
over, it is known that dynorphin, the
mature opioid peptide encoded by this
precursor gene, stimulates k opioid re-
ceptors (KORs) to inhibit locomotor activ-
ity. Perhaps reductions in KOR signaling
in the VTA, driven by decreases in dopa-mine release in NAc, stimulates running
behavior in a dopamine-independent
manner in the STAT3DAT KO mice?
In summary, the present data provide
important new insights into how leptin,
and other signaling molecules acting
through STAT3 in VTA dopamine neurons,
can influence physical activity. Endurance
training, such as distance running, often
induces feelings of well-being and happi-
ness, commonly referred to as ‘‘runner’s
high.’’ It will be interesting to determine if
reductions in STAT3 signaling in VTA
dopamine neurons explains this effect. If
so, perhaps inhibitors of STAT3 signaling
in VTA will increase willingness to exer-
cise, and increase energy expenditure, in
overweight individuals. However, it is not
too fanciful to speculate that such inhibi-
tors could boost endurance of distance
runners, offering an unfair advance in
competitive settings. The findings may
also be relevant to anorexia nervosa, a
condition associated with low circulating
levels of leptin and in which sufferers are
often hyperactive and prone to over-
exercising.Cell Metabolism 2REFERENCES
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While mesenchymal stem cells (MSCs) are rapidly cleared from the body following systemic transplantation,
their therapeutic benefits typically persist. In this issue, Liu et al. (2015) reveal that the ability of transplanted
MSCs to alleviate osteoporosis in systemic lupus erythematosus is maintained through epigenetic changes
conferred by secretory action of the MSCs.The promise of cell therapy in replacing or
regenerating damaged tissues and re-
turning tissue to homeostasis has ush-
ered in hundreds of clinical trials including
>500 that employ mesenchymal stem
cells (MSCs). MSCs differentiate into
osteogenic, chondrogenic, and adipo-genic lineages and are also appreciated
for their immunomodulatory properties
and ability to evade host immune attack
(Ankrum et al., 2014). Despite their im-
mune-evasiveness, transplanted MSCs
fail to persist in vivo and are thought to
impart therapeutic benefits via a ‘‘hit-and-run’’ mechanism (von Bahr et al.,
2012). Interestingly, these benefits remain
detectable long after the transplanted
MSCs disappear (Gnecchi et al., 2008;
Ranganath et al., 2012; von Bahr et al.,
2012). Multiple studies have demon-
strated that MSC-conditioned media2, October 6, 2015 ª2015 Elsevier Inc. 541
